Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes

Diabetes Care

Volumn 22, Issue 1, 1999, Pages 119-124

  Moses, Robert ^a,h   Carter, John ^d   Slobodniuk, Raymond ^a   Donnelly, Thomas ^e   Boyages, Steven ^b   Moffitt, Paul ^f   Colagiuri, Stephen ^c   Hopkins, Helen ^g   Kidson, Warren ^c  

^a Illawarra Regional Hospital   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d HORNSBY KU RING GAI HOSPITAL   (Australia)

^e JOHN HUNTER HOSPITAL   (Australia)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g NOVO NORDISK A S   (Denmark)

^h Diabetes Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; REPAGLINIDE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

AUSTRALIA; BLOOD GLUCOSE; C-PEPTIDE; CARBAMATES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PIPERIDINES; TRIGLYCERIDES;

EID: 0345434811     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.1.119     Document Type: Article

References (15)

1. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 47-68 (NIH publ. no. 95-1468)
2. Fertig BJ, Simmons DA, Martin DB: Therapy for diabetes. In Diabetes in America. Bethesda, MD, NIH publication no. 95-1468:519-540, 1995
3. Bailey CJ, Turner RC: Metformin. N Engl J Med 334:574-579, 1996
4. Alberti KGMM, Gries FA: Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diabet Med 5:275-281, 1988
5. DeFronzo RA, Goodman AN: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333:541-549, 1995
6. Hermann LS: Biguanides and sulfonylureas as combination therapy in NIDDM. Diabetes Care 13 (Suppl. 3):37-41, 1990
7. Hermann LS, Scherstén B, Bitzén P, Kjellström T, Lindgärde F, Melander A: Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care 17:1100-1109, 1994
8. Wolffenbuttel BH, Nijst L, Sels JP, Menheere PP, Müller PG, Kruseman AC: Effects of a new oral hypoglycemic agent, repaglinide, on metabolic control in sulphonylureatreated patients with NIDDM. Eur J Clin Pharmacol 45:113-116, 1993
9. Graul A, Castaňer J Repaglinide. Drugs Future 21:694-699, 1996
10. Fuhlendorff J, Rorsman P, Kofod H, Brand CL, Rolin B, MacKay P, Shymko R, Carr RD: Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47:345-351, 1998
11. Van Gaal LF, Van Acker KL, Damsbo P, De Leeuw IH: Metabolic effects of repaglinide, a new oral hypoglycemic agent in therapy-naive type 2 diabetics (Abstract). Diabetologia 38 (Suppl. 1):164, 1995
12. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 21 (Suppl. 1):S23-S29, 1998
13. Dunn CJ, Peters DH: Metformm: a review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49:721-749, 1995
14. U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
15. Scheen AJ: Clinical pharmacokinetics of metformin. Gin Pharmacokinet 30:359-371, 1996